Thienopiperidine
WebDEUTERATED THIENOPIPERIDINE DERIVATIVES, MANUFACTURING METHOD, AND APPLICATION THEREOF. 3315505 - EP16813692B1 - EPO Application Jun 21, 2016 - … WebDeuterated thienopiperidine derivatives, manufacturing method, and application thereof Grant 11,130,766 - Wang , et al. September 28, 2: 2024-09-28: Application of triacetyl-3-hydroxyphenyladenosine in preparation of pharmaceutical drug for preventing or treating non-alcoholic fatty liver disease Grant 11,058,703 - Zhu , et al. July 13, 2: 2024 ...
Thienopiperidine
Did you know?
Thienopyridines are a class of selective, irreversible ADP receptor/P2Y12 inhibitors used for their anti-platelet activity. They have a significant role in the management of cardiovascular disease. See more They are used in the management of peripheral artery disease, as well as the prevention of coronary stent thrombosis and strokes. See more Drugs in this class include: clopidogrel (Plavix), prasugrel (Effient), and ticlopidine (Ticlid). Tinoridine was actually a predecessor to this work. See more Ticagrelor (Brilinta) is often listed with thienopyridine inhibitors and has similar indications for use but is not a thienopyridine. It is a … See more WebBackground and purpose:There is growing interest in using cannabinoid type 2 (CB2) receptor agonists for the treatment of neuropathic pain. In this report, we describe the pharmacological characteristics of MDA7 (1-[(3-benzyl-3-methyl-2,3-dihydro-1-benzofuran-6-yl)carbonyl]piperidine), a novel CB2 receptor agonist.There is growing interest in using …
Web21 Sep 2011 · Our attention was drawn to the possibility of introducing thiophene or furan groups into the 5-position of 2-cycloalkylamino-substituted 1,3,4-thiadiazines because the most effective inhibitor of platelet aggregation is now considered to be the optimum drug clopidogrel of a new generation of annelated thienopiperidine derivatives [].However, the … WebDEUTERATED THIENOPIPERIDINE DERIVATIVES, MANUFACTURING METHOD, AND APPLICATION THEREOF. 3315505 - EP16813692B1 - EPO Application Jun 21, 2016 - Publication Mar 25, 2024 Guocheng WANG Jun ZHONG Xueyu XU.
Web[0002] Clopidogrel is one kind of thienopiperidine derivative medicine, which could efficiently inhibit the platelet activity, is one anti-platelet medicine widely used for acute coronary …
WebThe deuterated thienopiperidine derivatives in the present invention are of the following formula (I). The present invention also comprises the application of the deuterated …
WebThe deuterated thienopiperidine derivatives in the present invention are of a structure of the following formula (I). The present invention also comprises the application of the … monitor group revenueWebTiclopidine is the oldest thienopyridine available and is approved for secondary prevention of thrombotic strokes in aspirin-intolerant patients, and in combination with aspirin for … monitor group amsterdamWebRU-2024100116-A chemical patent summary. monitor group healthcareWebThe deuterated thienopiperidine derivatives in the present invention are of the following formula (I). The present invention also comprises the application of the deuterated … monitor gsm59c8WebThe THIENOPIPERIDINE DERIVATIVE AND USE THEREOF patent was assigned a Application Number # 17183616 – by the United States Patent and Trademark Office (USPTO). Patent … monitor gsm59caWebannelated thienopiperidine derivatives [8]. However, the maximum therapeutic effect of clopidogrel itself is achieved only after 4 – 7 days of treatment. Aspirin is added in order to accelerate the delayed action of the drug. However, inter-nal hemorrhaging and the manifestation of aspirin side ef-fects are possible with combined administration. monitor green screen problemWebthienopiperidine derivative with the following structure, which is a pro-drug of the 2-oxy-clopidogrel (metabolite of the clopidogrel), to improve the "clopidogrel resistance". [0005] … monitor group new business